Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome

Smathorn Thakolwiboon, Jenny Linnoila, Sean J. Pittock, Divyanshu Dubey, Anastasia Zekeridou

Research output: Contribution to journalArticlepeer-review

Abstract

Purkinje cell cytoplasmic autoantibody type 1 (PCA1), also known as anti-Yo, is a ‘high-risk’ paraneoplastic antibody, associated with rapidly progressive cerebellar syndrome. In patients with this syndrome, various MRI abnormalities have been documented, including atrophy in the cerebellum and brainstem, T2 hyperintensity in the brainstem and spinal cord, and cranial nerve enhancement. This report introduces an imaging finding, cerebellar leptomeningeal enhancement, which was observed in all three cases at early stages. Despite neurological deterioration, all patients underwent immunotherapy, and subsequent follow-up MRI revealed resolution of the leptomeningeal enhancement, suggesting that this feature is distinct from meningeal carcinomatosis.

Original languageEnglish (US)
Article number578293
JournalJournal of neuroimmunology
Volume387
DOIs
StatePublished - Feb 15 2024

Keywords

  • Anti-Yo
  • Leptomeningeal enhancement
  • Paraneoplastic
  • Purkinje cell cytoplasmic autoantibody type 1
  • Rapidly progressive cerebellar syndrome

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome'. Together they form a unique fingerprint.

Cite this